Diphtheria Toxin Based Molecules as Therapeutic Approaches
Publisher
Springer Netherlands
Reference46 articles.
1. Alexander RL, Ramage J, Kucera GL, Caligiuri MA, Frankel AE (2001) High affinity interleukin-3 receptor expression on blasts from patients with acute myelogenous leukemia correlates with cytotoxicity of a diphtheria toxin/IL-3 fusion protein. Leuk Res 25(10):875–881
2. Black JH, McCubrey JA, Willingham MC, Ramage J, Hogge DE, Frankel AE (2003) Diphtheria toxin-interleukin-3 fusion protein (DT(388)IL3) prolongs disease-free survival of leukemic immunocompromised mice. Leukemia 17(1):155–159
3. Blythman HE, Casellas P, Gros O, Gros P, Jansen FK, Paolucci F, Pau B, Vidal H (1981) Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells. Nature 290(5802):145–146
4. Brinkmann U, Mansfield E, Pastan I (1997) Effects of BCL-2 overexpression on the sensitivity of MCF-7 breast cancer cells to ricin, diphtheria and Pseudomonas toxin and immunotoxins. Apoptosis 2(2):192–198
5. Burbage C, Tagge EP, Harris B, Hall P, Fu T, Willingham MC, Frankel AE (1997) Ricin fusion toxin targeted to the human granulocyte-macrophage colony stimulating factor receptor is selectively toxic to acute myeloid leukemia cells. Leuk Res 21(7):681–690